Selectivity, ligand deconstruction, and cellular activity analysis of a BPTF bromodomain inhibitor

Steven E. Kirberger, Peter D. Ycas, Jorden A. Johnson, Chen Chen, Michael F. Ciccone, Rinette W.L. Woo, Andrew K. Urick, Huda Zahid, Ke Shi, Hideki Aihara, Sean D. McAllister, Mohammed Kashani-Sabet, Junwei Shi, Alex Dickson, Camila O. Dos Santos, William C.K. Pomerantz

Research output: Contribution to journalArticle

Abstract

Bromodomain and PHD finger containing protein transcription factor (BPTF) is an epigenetic protein involved in chromatin remodelling and is a potential anticancer target. The BPTF bromodomain has one reported small molecule inhibitor (AU1, rac-1). Here, advances made on the structure-activity relationship of a BPTF bromodomain ligand are reported using a combination of experimental and molecular dynamics simulations leading to the active enatiomer (S)-1. Additionally, a ligand deconstruction analysis was conducted to characterize important pharmacophores for engaging the BPTF bromodomain. These studies have been enabled by a protein-based fluorine NMR approach, highlighting the versatility of the method for selectivity, ligand deconstruction, and ligand binding. To enable future analysis of biological activity, cell growth analyses in a panel of cancer cell lines were carried out using CRISPR-Cas9 and (S)-1 to identify cell-based model systems that are sensitive to BPTF inhibition.

Original languageEnglish (US)
Pages (from-to)2020-2027
Number of pages8
JournalOrganic and Biomolecular Chemistry
Volume17
Issue number7
DOIs
StatePublished - Jan 1 2019

Fingerprint

inhibitors
selectivity
Ligands
ligands
proteins
Clustered Regularly Interspaced Short Palindromic Repeats
chromatin
Proteins
Chromatin Assembly and Disassembly
Fluorine
Cell growth
Molecular Dynamics Simulation
versatility
Structure-Activity Relationship
activity (biology)
Bioactivity
cultured cells
Epigenomics
Fingers
Chromatin

PubMed: MeSH publication types

  • Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

Cite this

Selectivity, ligand deconstruction, and cellular activity analysis of a BPTF bromodomain inhibitor. / Kirberger, Steven E.; Ycas, Peter D.; Johnson, Jorden A.; Chen, Chen; Ciccone, Michael F.; Woo, Rinette W.L.; Urick, Andrew K.; Zahid, Huda; Shi, Ke; Aihara, Hideki; McAllister, Sean D.; Kashani-Sabet, Mohammed; Shi, Junwei; Dickson, Alex; Dos Santos, Camila O.; Pomerantz, William C.K.

In: Organic and Biomolecular Chemistry, Vol. 17, No. 7, 01.01.2019, p. 2020-2027.

Research output: Contribution to journalArticle

Kirberger, SE, Ycas, PD, Johnson, JA, Chen, C, Ciccone, MF, Woo, RWL, Urick, AK, Zahid, H, Shi, K, Aihara, H, McAllister, SD, Kashani-Sabet, M, Shi, J, Dickson, A, Dos Santos, CO & Pomerantz, WCK 2019, 'Selectivity, ligand deconstruction, and cellular activity analysis of a BPTF bromodomain inhibitor', Organic and Biomolecular Chemistry, vol. 17, no. 7, pp. 2020-2027. https://doi.org/10.1039/c8ob02599a
Kirberger, Steven E. ; Ycas, Peter D. ; Johnson, Jorden A. ; Chen, Chen ; Ciccone, Michael F. ; Woo, Rinette W.L. ; Urick, Andrew K. ; Zahid, Huda ; Shi, Ke ; Aihara, Hideki ; McAllister, Sean D. ; Kashani-Sabet, Mohammed ; Shi, Junwei ; Dickson, Alex ; Dos Santos, Camila O. ; Pomerantz, William C.K. / Selectivity, ligand deconstruction, and cellular activity analysis of a BPTF bromodomain inhibitor. In: Organic and Biomolecular Chemistry. 2019 ; Vol. 17, No. 7. pp. 2020-2027.
@article{abf0d66be6aa45fe8655bbb28326c603,
title = "Selectivity, ligand deconstruction, and cellular activity analysis of a BPTF bromodomain inhibitor",
abstract = "Bromodomain and PHD finger containing protein transcription factor (BPTF) is an epigenetic protein involved in chromatin remodelling and is a potential anticancer target. The BPTF bromodomain has one reported small molecule inhibitor (AU1, rac-1). Here, advances made on the structure-activity relationship of a BPTF bromodomain ligand are reported using a combination of experimental and molecular dynamics simulations leading to the active enatiomer (S)-1. Additionally, a ligand deconstruction analysis was conducted to characterize important pharmacophores for engaging the BPTF bromodomain. These studies have been enabled by a protein-based fluorine NMR approach, highlighting the versatility of the method for selectivity, ligand deconstruction, and ligand binding. To enable future analysis of biological activity, cell growth analyses in a panel of cancer cell lines were carried out using CRISPR-Cas9 and (S)-1 to identify cell-based model systems that are sensitive to BPTF inhibition.",
author = "Kirberger, {Steven E.} and Ycas, {Peter D.} and Johnson, {Jorden A.} and Chen Chen and Ciccone, {Michael F.} and Woo, {Rinette W.L.} and Urick, {Andrew K.} and Huda Zahid and Ke Shi and Hideki Aihara and McAllister, {Sean D.} and Mohammed Kashani-Sabet and Junwei Shi and Alex Dickson and {Dos Santos}, {Camila O.} and Pomerantz, {William C.K.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1039/c8ob02599a",
language = "English (US)",
volume = "17",
pages = "2020--2027",
journal = "Organic and Biomolecular Chemistry",
issn = "1477-0520",
publisher = "Royal Society of Chemistry",
number = "7",

}

TY - JOUR

T1 - Selectivity, ligand deconstruction, and cellular activity analysis of a BPTF bromodomain inhibitor

AU - Kirberger, Steven E.

AU - Ycas, Peter D.

AU - Johnson, Jorden A.

AU - Chen, Chen

AU - Ciccone, Michael F.

AU - Woo, Rinette W.L.

AU - Urick, Andrew K.

AU - Zahid, Huda

AU - Shi, Ke

AU - Aihara, Hideki

AU - McAllister, Sean D.

AU - Kashani-Sabet, Mohammed

AU - Shi, Junwei

AU - Dickson, Alex

AU - Dos Santos, Camila O.

AU - Pomerantz, William C.K.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Bromodomain and PHD finger containing protein transcription factor (BPTF) is an epigenetic protein involved in chromatin remodelling and is a potential anticancer target. The BPTF bromodomain has one reported small molecule inhibitor (AU1, rac-1). Here, advances made on the structure-activity relationship of a BPTF bromodomain ligand are reported using a combination of experimental and molecular dynamics simulations leading to the active enatiomer (S)-1. Additionally, a ligand deconstruction analysis was conducted to characterize important pharmacophores for engaging the BPTF bromodomain. These studies have been enabled by a protein-based fluorine NMR approach, highlighting the versatility of the method for selectivity, ligand deconstruction, and ligand binding. To enable future analysis of biological activity, cell growth analyses in a panel of cancer cell lines were carried out using CRISPR-Cas9 and (S)-1 to identify cell-based model systems that are sensitive to BPTF inhibition.

AB - Bromodomain and PHD finger containing protein transcription factor (BPTF) is an epigenetic protein involved in chromatin remodelling and is a potential anticancer target. The BPTF bromodomain has one reported small molecule inhibitor (AU1, rac-1). Here, advances made on the structure-activity relationship of a BPTF bromodomain ligand are reported using a combination of experimental and molecular dynamics simulations leading to the active enatiomer (S)-1. Additionally, a ligand deconstruction analysis was conducted to characterize important pharmacophores for engaging the BPTF bromodomain. These studies have been enabled by a protein-based fluorine NMR approach, highlighting the versatility of the method for selectivity, ligand deconstruction, and ligand binding. To enable future analysis of biological activity, cell growth analyses in a panel of cancer cell lines were carried out using CRISPR-Cas9 and (S)-1 to identify cell-based model systems that are sensitive to BPTF inhibition.

UR - http://www.scopus.com/inward/record.url?scp=85061480713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061480713&partnerID=8YFLogxK

U2 - 10.1039/c8ob02599a

DO - 10.1039/c8ob02599a

M3 - Article

C2 - 30706071

AN - SCOPUS:85061480713

VL - 17

SP - 2020

EP - 2027

JO - Organic and Biomolecular Chemistry

JF - Organic and Biomolecular Chemistry

SN - 1477-0520

IS - 7

ER -